SeaSpine’s Growing Portfolio Drives Share Gains

SeaSpine reported 2Q22 orthopedic sales of $56.3 million, +18.7% compared to 2Q21.

The company increased its surgical volumes by 22% over the second quarter of last year, driving revenue per case growth in the mid-single digits. SeaSpine leadership said an increasingly complete product offering across spinal implants and orthobiologics,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us